Found 549753 clinical trials
Sort by:
Ulcer Pomegranate Muffins
Not Applicable
Completed
- Conditions
- Anti-UlcerativeGastric
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- University of Lahore
- Target Recruit Count
- 82
- Registration Number
- NCT07123259
- Locations
- 🇵🇰
Sana Noreen, Lahore, Pakistan
Autoinflation as a Eustachian Tube Rehabilitation
Not Applicable
Completed
- Conditions
- Otitis Media With Effusion (OME)Eustachian Tube Dysfunction
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Pusan National University Hospital
- Target Recruit Count
- 54
- Registration Number
- NCT07122999
- Locations
- 🇰🇷
Pusan National University Hospital, Busan, Seo-Gu, Korea, Republic of
Glioblastoma Imaging for the Detection of Tumor Progression Using APTw-CEST MRI
Not Applicable
Recruiting
- Conditions
- Glioblastoma
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Erasmus Medical Center
- Target Recruit Count
- 120
- Registration Number
- NCT07121842
- Locations
- 🇳🇱
Amsterdam UMC, Amsterdam, Netherlands
🇳🇱Leiden UMC, Leiden, Netherlands
🇳🇱Erasmus MC, Rotterdam, Netherlands
Shenbai Granules for Preventing Recurrence of Low-Risk Colorectal Adenomas
Not Applicable
Not yet recruiting
- Conditions
- Colorectal AdenomaTCMLow Risk
- Interventions
- Drug: Shenbai GranulesDrug: Placebo
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Jiangsu Famous Medical Technology Co., Ltd.
- Target Recruit Count
- 450
- Registration Number
- NCT07123116
- Locations
- 🇨🇳
Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
A Study on the Efficacy and Safety of Irinotecan Liposome (II), 5-FU/LV in Combination With Bevacizumab for the Treatment of Advanced Colorectal Cancer
Not Applicable
Not yet recruiting
- Conditions
- Colorectal Cancer
- Interventions
- Drug: Bevacizumab,Irinotecan liposome (II),5-FU/LV
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Sanjun Cai
- Target Recruit Count
- 300
- Registration Number
- NCT07123441
- Locations
- 🇨🇳
Fudan University, Cancer Hospital, Shanghai, Shanghai, China
Efficacy and Safety of Keverprazan-amoxicillin Dual Therapy for Helicobacter Pylori First-line Treatment
Not Applicable
Recruiting
- Conditions
- Helicobacter Pylori
- Interventions
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- Target Recruit Count
- 414
- Registration Number
- NCT07122024
- Locations
- 🇨🇳
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
AI for Detection of Brain Aneurysm: Low-cost Opportunistic Screening
Not Applicable
Not yet recruiting
- Conditions
- Intracranial Aneurysm
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Ziekenhuis Oost-Limburg
- Target Recruit Count
- 10000
- Registration Number
- NCT07123818
Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy
Not yet recruiting
- Conditions
- CIDP - Chronic Inflammatory Demyelinating PolyneuropathyGuillain-Barré Syndrome (GBS)
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- University of Erlangen-Nürnberg Medical School
- Target Recruit Count
- 30
- Registration Number
- NCT07121985
Feasibility and Outcomes of 3D-printed External Cranial Orthosis After Craniectomy
Active, not recruiting
- Conditions
- Traumatic Brain InjuryAcquired Brain InjuryBrain TumorStroke
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Tan Tock Seng Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT07122752
- Locations
- 🇸🇬
Tan Tock Seng Hospital, Singapore, Singapore
Preliminary Clinical Study on the Effect of Bacillus Subtilis on the Efficacy of Infliximab in Patients With Crohn's Disease
Not Applicable
Recruiting
- Conditions
- Mild to Severe Crohns Disease
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Target Recruit Count
- 24
- Registration Number
- NCT07123207
- Locations
- 🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China